Exposure to organic solvents, such as varnish and paint can increase the risk of developing multiple sclerosis (MS), according to a large Swedish study. The risk was particularly found in people who...
The Government has revealed that it will make a decision on whether it will legalise cannabis for medical use in the coming weeks.
Home Secretary Sajid Javid ordered an evidence review of the drug...
A large population-based cohort study, which looked into the effects of three common air pollutants in people with multiple sclerosis (MS) has found no significant link between long term exposure and...
The Department of Health and Social Care has asked the National Institute for Health and Care Excellence (NICE) to produce guidance on using ocrelizumab (Ocrevus) for treating primary progressive...
Cannabinoid Biotech Company Axim has received a patent allowance on its method of extracting and purifying THC (cannabinoid molecule delta-9-tetrahydrocannabinol) in America.
The process is said to...
The National Institute for Health Care and Excellence (NICE) has approved ocrelizumab (Ocrevus) as a treatment option for people with active relapsing remitting multiple sclerosis (RRMS).
Back in...
New guidance, set to come into effect this summer, will mean that people who are awarded the highest level of support under PIP – and where their needs are expected to stay the same or increase –...
Researchers at Karolinska Institutet in Sweden have discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They...
A new clinical trial testing a disease-modifying drug for multiple sclerosis (MS) will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
The...
Both high body mass index (BMI) and smoking tobacco are known risk factors for developing multiple sclerosis (MS). However, it is unclear whether BMI, like smoking, is a risk factor for the secondary...
